BVF INC/IL Diversified Active

Location: San Francisco, CA

CIK: 0001056807 · Show all filings

Period: Q3 2025 (← Previous) (Next →)

Filing Date: Nov 14, 2025

Total Value: $2.467B (100.0% shares, 0.0% debt)

Holdings (46)

KYMR KYMERA THERAPEUTICS INC 12.6%

Value $311M Shares 5,502,710 Est. Cost — Unrealized —

RVMD REVOLUTION MEDICINES INC 7.5%

Value $186M Shares 3,974,913 Est. Cost — Unrealized —

PTGX PROTAGONIST THERAPEUTICS INC 6.9%

Value $170M Shares 2,560,916 Est. Cost — Unrealized —

MLTX MOONLAKE IMMUNOTHERAPEUTICS 5.7%

Value $142M Shares 19,751,284 Est. Cost — Unrealized —

— CIDARA THERAPEUTICS INC 5.5%

Value $135M Shares 1,414,165 Est. Cost — Unrealized —

GHRS GH RESEARCH PLC 5.1%

Value $126M Shares 8,827,712 Est. Cost — Unrealized —

MIRM MIRUM PHARMACEUTICALS INC 4.4%

Value $110M Shares 1,495,290 Est. Cost — Unrealized —

XOMA XOMA ROYALTY CORPORATION 4.0%

Value $99.83M Shares 2,590,303 Est. Cost — Unrealized —

GPCR STRUCTURE THERAPEUTICS INC 3.6%

Value $89.71M Shares 3,203,917 Est. Cost — Unrealized —

KURA KURA ONCOLOGY INC 3.1%

Value $76.26M Shares 8,617,162 Est. Cost — Unrealized —

SEPN SEPTERNA INC 3.1%

Value $75.54M Shares 4,015,790 Est. Cost — Unrealized —

PVLA PALVELLA THERAPEUTICS INC NE 3.0%

Value $72.8M Shares 1,161,249 Est. Cost — Unrealized —

NKTR NEKTAR THERAPEUTICS 2.9%

Value $72.64M Shares 1,276,595 Est. Cost — Unrealized —

ZYME ZYMEWORKS INC 2.7%

Value $67.27M Shares 3,938,641 Est. Cost — Unrealized —

AXSM AXSOME THERAPEUTICS INC 2.4%

Value $59.12M Shares 486,757 Est. Cost — Unrealized —

ACIU AC IMMUNE SA 2.3%

Value $57.29M Shares 19,822,436 Est. Cost — Unrealized —

IMCR IMMUNOCORE HLDGS PLC 2.3%

Value $57.19M Shares 1,574,288 Est. Cost — Unrealized —

OLMA OLEMA PHARMACEUTICALS INC 2.1%

Value $51.85M Shares 5,295,893 Est. Cost — Unrealized —

TYRA TYRA BIOSCIENCES INC 2.1%

Value $51.06M Shares 3,649,794 Est. Cost — Unrealized —

ABVX ABIVAX SA 1.9%

Value $47.38M Shares 558,031 Est. Cost — Unrealized —

GLUE MONTE ROSA THERAPEUTICS INC 1.7%

Value $41.94M Shares 5,660,132 Est. Cost — Unrealized —

FDMT 4D MOLECULAR THERAPEUTICS IN 1.6%

Value $40.23M Shares 4,629,289 Est. Cost — Unrealized —

STOK STOKE THERAPEUTICS INC 1.6%

Value $38.94M Shares 1,657,096 Est. Cost — Unrealized —

CGEM CULLINAN THERAPEUTICS INC 1.4%

Value $34.1M Shares 5,750,683 Est. Cost — Unrealized —

CELC CELCUITY INC 1.3%

Value $32.53M Shares 658,421 Est. Cost — Unrealized —

XNCR XENCOR INC 1.3%

Value $32.14M Shares 2,740,141 Est. Cost — Unrealized —

FHTX FOGHORN THERAPEUTICS INC 1.1%

Value $25.93M Shares 5,302,000 Est. Cost — Unrealized —

ANNX ANNEXON INC 0.9%

Value $21.35M Shares 7,000,000 Est. Cost — Unrealized —

— REPARE THERAPEUTICS INC 0.7%

Value $18.19M Shares 10,333,600 Est. Cost — Unrealized —

AVTX AVALO THERAPEUTICS INC 0.7%

Value $17.23M Shares 1,355,256 Est. Cost — Unrealized —

CMPX COMPASS THERAPEUTICS INC 0.7%

Value $16.63M Shares 4,750,000 Est. Cost — Unrealized —

CBIO CRESCENT BIOPHARMA INC. 0.7%

Value $16.5M Shares 1,387,863 Est. Cost — Unrealized —

ELDN ELEDON PHARMACEUTICALS INC 0.7%

Value $16.3M Shares 6,293,282 Est. Cost — Unrealized —

TCRX TSCAN THERAPEUTICS INC 0.4%

Value $9.511M Shares 5,226,074 Est. Cost — Unrealized —

PEPG PEPGEN INC 0.4%

Value $8.847M Shares 1,915,000 Est. Cost — Unrealized —

XFOR X4 PHARMACEUTICALS INC 0.3%

Value $7.639M Shares 2,233,742 Est. Cost — Unrealized —

IMUX IMMUNIC INC 0.3%

Value $6.747M Shares 7,652,972 Est. Cost — Unrealized —

IMA IMAGENEBIO INC 0.3%

Value $6.537M Shares 802,102 Est. Cost — Unrealized —

MOLN MOLECULAR PARTNERS AG 0.2%

Value $5.023M Shares 1,353,968 Est. Cost — Unrealized —

IVA INVENTIVA SA 0.2%

Value $3.972M Shares 686,040 Est. Cost — Unrealized —

TENX TENAX THERAPEUTICS INC 0.1%

Value $2.584M Shares 339,549 Est. Cost — Unrealized —

— ESSA PHARMA INC 0.1%

Value $2.229M Shares 11,668,473 Est. Cost — Unrealized —

SABS SAB BIOTHERAPEUTICS INC 0.1%

Value $1.875M Shares 932,697 Est. Cost — Unrealized —

FBRX FORTE BIOSCIENCES INC 0.0%

Value $980K Shares 65,350 Est. Cost — Unrealized —

ENGNW ENGENE HOLDINGS INC 0.0%

Value $681K Shares 945,402 Est. Cost — Unrealized —

— NLS PHARMACEUTICS LTD 0.0%

Value $263K Shares 143,676 Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
KYMR	KYMERA THERAPEUTICS INC	5,502,710	$311M	12.6%	—	—	COM	501575104
RVMD	REVOLUTION MEDICINES INC	3,974,913	$186M	7.5%	—	—	COM	76155X100
PTGX	PROTAGONIST THERAPEUTICS INC	2,560,916	$170M	6.9%	—	—	COM	74366E102
MLTX	MOONLAKE IMMUNOTHERAPEUTICS	19,751,284	$142M	5.7%	—	—	CLASS A ORD	61559X104
—	CIDARA THERAPEUTICS INC	1,414,165	$135M	5.5%	—	—	COM NEW	171757206
GHRS	GH RESEARCH PLC	8,827,712	$126M	5.1%	—	—	ORDINARY SHARES	G3855L106
MIRM	MIRUM PHARMACEUTICALS INC	1,495,290	$110M	4.4%	—	—	COM	604749101
XOMA	XOMA ROYALTY CORPORATION	2,590,303	$99.83M	4.0%	—	—	COM NEW	98419J206
GPCR	STRUCTURE THERAPEUTICS INC	3,203,917	$89.71M	3.6%	—	—	SPONSORED ADS	86366E106
KURA	KURA ONCOLOGY INC	8,617,162	$76.26M	3.1%	—	—	COM	50127T109
SEPN	SEPTERNA INC	4,015,790	$75.54M	3.1%	—	—	COM	81734D104
PVLA	PALVELLA THERAPEUTICS INC NE	1,161,249	$72.8M	3.0%	—	—	COM	697947109
NKTR	NEKTAR THERAPEUTICS	1,276,595	$72.64M	2.9%	—	—	COM NEW	640268306
ZYME	ZYMEWORKS INC	3,938,641	$67.27M	2.7%	—	—	COM	98985Y108
AXSM	AXSOME THERAPEUTICS INC	486,757	$59.12M	2.4%	—	—	COM	05464T104
ACIU	AC IMMUNE SA	19,822,436	$57.29M	2.3%	—	—	SHS	H00263105
IMCR	IMMUNOCORE HLDGS PLC	1,574,288	$57.19M	2.3%	—	—	ADS	45258D105
OLMA	OLEMA PHARMACEUTICALS INC	5,295,893	$51.85M	2.1%	—	—	COM	68062P106
TYRA	TYRA BIOSCIENCES INC	3,649,794	$51.06M	2.1%	—	—	COM	90240B106
ABVX	ABIVAX SA	558,031	$47.38M	1.9%	—	—	SPONSORED ADS	00370M103
GLUE	MONTE ROSA THERAPEUTICS INC	5,660,132	$41.94M	1.7%	—	—	COM	61225M102
FDMT	4D MOLECULAR THERAPEUTICS IN	4,629,289	$40.23M	1.6%	—	—	COM	35104E100
STOK	STOKE THERAPEUTICS INC	1,657,096	$38.94M	1.6%	—	—	COM	86150R107
CGEM	CULLINAN THERAPEUTICS INC	5,750,683	$34.1M	1.4%	—	—	COM	230031106
CELC	CELCUITY INC	658,421	$32.53M	1.3%	—	—	COM	15102K100
XNCR	XENCOR INC	2,740,141	$32.14M	1.3%	—	—	COM	98401F105
FHTX	FOGHORN THERAPEUTICS INC	5,302,000	$25.93M	1.1%	—	—	COM	344174107
ANNX	ANNEXON INC	7,000,000	$21.35M	0.9%	—	—	COM	03589W102
—	REPARE THERAPEUTICS INC	10,333,600	$18.19M	0.7%	—	—	COM	760273102
AVTX	AVALO THERAPEUTICS INC	1,355,256	$17.23M	0.7%	—	—	COM NEW	05338F306
CMPX	COMPASS THERAPEUTICS INC	4,750,000	$16.63M	0.7%	—	—	COM	20454B104
CBIO	CRESCENT BIOPHARMA INC.	1,387,863	$16.5M	0.7%	—	—	COM	G2545C104
ELDN	ELEDON PHARMACEUTICALS INC	6,293,282	$16.3M	0.7%	—	—	COM	28617K101
TCRX	TSCAN THERAPEUTICS INC	5,226,074	$9.511M	0.4%	—	—	COM	89854M101
PEPG	PEPGEN INC	1,915,000	$8.847M	0.4%	—	—	COM	713317105
XFOR	X4 PHARMACEUTICALS INC	2,233,742	$7.639M	0.3%	—	—	COM NEW	98420X202
IMUX	IMMUNIC INC	7,652,972	$6.747M	0.3%	—	—	COM	4525EP101
IMA	IMAGENEBIO INC	802,102	$6.537M	0.3%	—	—	COM	45175G207
MOLN	MOLECULAR PARTNERS AG	1,353,968	$5.023M	0.2%	—	—	ADS	60853G106
IVA	INVENTIVA SA	686,040	$3.972M	0.2%	—	—	ADS	46124U107
TENX	TENAX THERAPEUTICS INC	339,549	$2.584M	0.1%	—	—	COM NEW	88032L605
—	ESSA PHARMA INC	11,668,473	$2.229M	0.1%	—	—	COM NEW	29668H708
SABS	SAB BIOTHERAPEUTICS INC	932,697	$1.875M	0.1%	—	—	COM NEW	78397T202
FBRX	FORTE BIOSCIENCES INC	65,350	$980K	0.0%	—	—	COM NEW	34962G208
ENGNW	ENGENE HOLDINGS INC	945,402	$681K	0.0%	—	—	*W EXP 10/31/202	29286M113
—	NLS PHARMACEUTICS LTD	143,676	$263K	0.0%	—	—	COM NEW	H57830137